Literature DB >> 15739047

Frontotemporal white matter changes in amyotrophic lateral sclerosis.

Sharon Abrahams1, Laura H Goldstein, John Suckling, Virginia Ng, Andy Simmons, Xavier Chitnis, Louise Atkins, Steve C R Williams, P N Leigh.   

Abstract

Cognitive dysfunction can occur in some patients with amyotrophic lateral sclerosis (ALS) who are not suffering from dementia. The most striking and consistent cognitive deficit has been found using tests of verbal fluency. ALS patients with verbal fluency deficits have shown functional imaging abnormalities predominantly in frontotemporal regions using positron emission tomography (PET). This study used automated volumetric voxel-based analysis of grey and white matter densities of structural magnetic resonance imaging (MRI) scans to explore the underlying pattern of structural cerebral change in nondemented ALS patients with verbal fluency deficits. Two groups of ALS patients, defined by the presence or absence of cognitive impairment on the basis of the Written Verbal Fluency Test (ALSi, cognitively impaired, n=11; ALSu, cognitively unimpaired n=12) were compared with healthy age matched controls (n=12). A comparison of the ALSi group with controls revealed significantly (p<0.002) reduced white matter volume in extensive motor and non-motor regions, including regions corresponding to frontotemporal association fibres. These patients demonstrated a corresponding cognitive profile of executive and memory dysfunction. Less extensive white matter reductions were revealed in the comparison of the ALSu and control groups in regions corresponding to frontal association fibres. White matter volumes were also found to correlate with performance on memory tests. There were no significant reductions in grey matter volume in the comparison of either patient group with controls. The structural white matter abnormalities in frontal and temporal regions revealed here may underlie the cognitive and functional imaging abnormalities previously reported in non-demented ALS patients. The results also suggest that extra-motor structural abnormalities may be present in ALS patients with no evidence of cognitive change. The findings support the hypothesis of a continuum of extra-motor cerebral and cognitive change in this disorder.

Entities:  

Mesh:

Year:  2005        PMID: 15739047     DOI: 10.1007/s00415-005-0646-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain.

Authors:  E T Bullmore; J Suckling; S Overmeyer; S Rabe-Hesketh; E Taylor; M J Brammer
Journal:  IEEE Trans Med Imaging       Date:  1999-01       Impact factor: 10.048

2.  Simulation of MRI cluster plots and application to neurological segmentation.

Authors:  A Simmons; S R Arridge; G J Barker; S C Williams
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

3.  Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease.

Authors:  R Gallassi; P Montagna; A Morreale; S Lorusso; P Tinuper; R Daidone; E Lugaresi
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

4.  Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS).

Authors:  S Abrahams; P N Leigh; A Harvey; G N Vythelingum; D Grisé; L H Goldstein
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

5.  The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

Authors:  J J Kew; L H Goldstein; P N Leigh; S Abrahams; N Cosgrave; R E Passingham; R S Frackowiak; D J Brooks
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

6.  Visuospatial judgment. A clinical test.

Authors:  A L Benton; N R Varney; K D Hamsher
Journal:  Arch Neurol       Date:  1978-06

7.  Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome.

Authors:  T van Amelsvoort; E Daly; D Robertson; J Suckling; V Ng; H Critchley; M J Owen; J Henry; K C Murphy; D G Murphy
Journal:  Br J Psychiatry       Date:  2001-05       Impact factor: 9.319

8.  Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS.

Authors:  C M Ellis; J Suckling; E Amaro; E T Bullmore; A Simmons; S C Williams; P N Leigh
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

9.  Amyotrophic lateral sclerosis severity scale.

Authors:  A D Hillel; R M Miller; K Yorkston; E McDonald; F H Norris; N Konikow
Journal:  Neuroepidemiology       Date:  1989       Impact factor: 3.282

10.  Frontal lobe atrophy in motor neuron diseases.

Authors:  J A Kiernan; A J Hudson
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

View more
  74 in total

Review 1.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

Review 3.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

4.  Right hemisphere dysfunction and emotional processing in ALS: an fMRI study.

Authors:  A Palmieri; M Naccarato; S Abrahams; M Bonato; C D'Ascenzo; S Balestreri; V Cima; G Querin; R Dal Borgo; L Barachino; C Volpato; C Semenza; E Pegoraro; C Angelini; G Sorarù
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

5.  Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study.

Authors:  M Cirillo; F Esposito; G Tedeschi; G Caiazzo; A Sagnelli; G Piccirillo; R Conforti; F Tortora; M R Monsurrò; S Cirillo; F Trojsi
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

Review 6.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

7.  Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited.

Authors:  Caroline A Sage; Wim Van Hecke; Ronald Peeters; Jan Sijbers; Wim Robberecht; Paul Parizel; Guy Marchal; Alexander Leemans; Stefan Sunaert
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

8.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

9.  Deficits in sentence expression in amyotrophic lateral sclerosis.

Authors:  Sharon Ash; Christopher Olm; Corey T McMillan; Ashley Boller; David J Irwin; Leo McCluskey; Lauren Elman; Murray Grossman
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

Review 10.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.